lactic acid has been researched along with nevirapine in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Averitt, D; Kumar, PN; Pakes, GE; Pappa, KA; Rodriguez-French, A; Shaefer, MS; Tashima, KT; Thompson, MA; Wannamaker, PG; Williams, VC | 1 |
| Falagas, ME; Kopterides, P; Panos, G | 1 |
| Castelnuovo, B; Kambugu, A; Mugasha, EB; Ocama, P; Songa, PM | 1 |
| del Mar Gutiérrez, M; Díaz-Delfín, J; Domingo, JC; Domingo, P; Gallego-Escuredo, JM; Giralt, M; Gracia Mateo, M; Villarroya, F | 1 |
| Kuo, YC; Lin, PI; Wang, CC | 1 |
1 trial(s) available for lactic acid and nevirapine
| Article | Year |
|---|---|
A prospective, 96-week study of the impact of Trizivir, Combivir/nelfinavir, and lamivudine/stavudine/nelfinavir on lipids, metabolic parameters and efficacy in antiretroviral-naive patients: effect of sex and ethnicity.
Topics: Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Black or African American; CD4 Lymphocyte Count; Cholesterol; Dideoxynucleosides; Drug Combinations; Female; Hispanic or Latino; HIV Infections; HIV-1; Humans; Hyperlipidemias; Lactic Acid; Lamivudine; Male; Nelfinavir; Nevirapine; Prospective Studies; Sex Factors; Stavudine; Treatment Outcome; Triglycerides; Zidovudine | 2006 |
5 other study(ies) available for lactic acid and nevirapine
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Hyperlactatemia due to nevirapine.
Topics: Adult; Anti-HIV Agents; Humans; Lactic Acid; Male; Nevirapine; Reverse Transcriptase Inhibitors | 2006 |
Symptomatic hyperlactatemia associated with nucleoside analogue reverse-transcriptase inhibitor use in HIV-infected patients: a report of 24 cases in a resource-limited setting (Uganda).
Topics: Acidosis, Lactic; Adult; Anti-HIV Agents; Female; HIV Infections; Humans; Lactic Acid; Lamivudine; Male; Middle Aged; Nevirapine; Reverse Transcriptase Inhibitors; Stavudine; Uganda | 2007 |
Effects of nevirapine and efavirenz on human adipocyte differentiation, gene expression, and release of adipokines and cytokines.
Topics: Adipocytes; Adipogenesis; Adipokines; Alkynes; Anti-Retroviral Agents; Benzoxazines; CCAAT-Enhancer-Binding Protein-alpha; Cell Survival; Cells, Cultured; Cyclopropanes; Cytokines; Down-Regulation; Gene Expression; Hepatocyte Growth Factor; Humans; Lactic Acid; Microbial Sensitivity Tests; Nevirapine; Plasminogen Activator Inhibitor 1; PPAR gamma; RNA-Directed DNA Polymerase; Sterol Regulatory Element Binding Protein 1 | 2011 |
Targeting nevirapine delivery across human brain microvascular endothelial cells using transferrin-grafted poly(lactide-co-glycolide) nanoparticles.
Topics: Brain; Cell Line; Drug Carriers; Endothelial Cells; Humans; Lactic Acid; Microscopy, Electron, Scanning; Microscopy, Electron, Transmission; Nanoparticles; Nevirapine; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Transferrin | 2011 |